Patterns and trends of transcatheter aortic valve implantation in italy. insights from RISPEVA
| Autor: | Alfredo Marchese, Alberto Cremonesi, Pietro Giudice, Arturo Giordano, Roberto Bonmassari, Giuseppe Biondi-Zoccai, Nicola Corcione, Patrizia Presbitero, Elvis Brscic, Sergio Berti, Carlo Pierli, Gennaro Sardella, Luca Testa, Ciro Indolfi, Nedy Brambilla, Anna Sonia Petronio, Francesco Bedogni, Antonio L. Bartorelli |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Aortic valve
medicine.medical_specialty aortic valve stenosis 030204 cardiovascular system & hematology registry 03 medical and health sciences 0302 clinical medicine Disease registry male Internal medicine Severity of illness italy medicine 80 and over aortic regurgitation aortic stenosis transcatheter aortic valve implantation aged aged 80 and over aortic valve comorbidity female humans prospective studies registries risk factors severity of illness index transcatheter aortic valve replacement treatment outcome cardiology and cardiovascular medicine 030212 general & internal medicine Risk factor Prospective cohort study Aged 80 and over Framingham Risk Score business.industry General Medicine medicine.disease Stenosis medicine.anatomical_structure Aortic valve stenosis Cardiology business |
| Popis: | AIMS Clinical trials have shown that transcatheter aortic valve implantation for aortic stenosis compares favorably to surgical replacement in high-risk patients and is superior to medical therapy in those at prohibitive risk. There is uncertainty however on patterns and trends in transcatheter aortic valve implantation, especially focusing on Italy. METHODS The RISPEVA study is a prospective Italian registry including 21 institutions. Patients have been enrolled since late 2012, and data collection includes several baseline, procedural, in-hospital, and follow-up details. For the present analysis on patterns and trends, we focused on patients enrolled between 2012 and 2015, and as primary variable on the prevalence of high versus prohibitive surgical risk, limiting our scope to procedural outcomes. RESULTS A total of 1157 patients were included. The temporal breakdown was 376 (33%) patients enrolled in 2013, 408 (35%) in 2014, and 373 (32%) in 2015. Several patient features differed over time, including risk score, peripheral artery disease, end-stage pulmonary disease, and prior valvuloplasty (all P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|